The upregulation of HIF-1α can be demonstrated efficacy in ameliorating symptoms of ARDS and sepsis through mechanisms, such as attenuating inflammatory factor expression, reducing oxidative stress, facilitating metabolic reprogramming, and modulating mitochondrial biogenesis. This evidence concerns the gene HIF1A and acute respiratory distress syndrome.